137 related articles for article (PubMed ID: 33426491)
1. Usefulness of robot-assisted radical prostatectomy in a patient with oligometastatic castration-resistant prostate cancer.
Koie T; Hagiwara N; Yamada T; Kondo H; Ito H; Tomioka M; Kawashima K; Kato D; Iinuma K; Nakane K
IJU Case Rep; 2021 Jan; 4(1):26-28. PubMed ID: 33426491
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer.
Koie T; Hashimoto Y; Suzuki Y; Hatayama Y; Kimura F
Case Rep Urol; 2020; 2020():5627548. PubMed ID: 33005471
[TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
4. Left testicular and pulmonary metastases of mucinous adenocarcinoma of the prostate after robot-assisted radical prostatectomy.
Kato K; Kamei J; Yanase A; Yokoyama H; Sugihara T; Ando S; Hirota Y; Sano N; Kume H; Fujimura T
IJU Case Rep; 2023 Jul; 6(4):222-225. PubMed ID: 37405027
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
6. Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate.
Li X; Xi H; Cheng X; Yu Y; Zhang C; Wang G; Zhou X
Front Endocrinol (Lausanne); 2023; 14():1123934. PubMed ID: 36843605
[TBL] [Abstract][Full Text] [Related]
7. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.
Sugimoto M; Kato T; Tohi Y; Shimizu Y; Matsumoto R; Inoue T; Takezawa Y; Masui K; Sasaki H; Hirama H; Saito S; Egawa S; Kamoto T; Teramukai S; Kojima S; Kikuchi T; Kakehi Y
BMC Urol; 2022 Sep; 22(1):151. PubMed ID: 36104667
[TBL] [Abstract][Full Text] [Related]
8. First case report of robot-assisted radical cystectomy for bladder cancer that developed after salvage radiotherapy following radical prostatectomy for prostate cancer.
Oka S; Sakaguchi K; Hayashida M; Ito S; Kurosawa K; Urakami S
IJU Case Rep; 2023 Sep; 6(5):310-313. PubMed ID: 37667760
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal invasion of prostate cancer directly confirmed during robot-assisted radical prostatectomy.
Ohyama T; Shimbo M; Komatsu K; Endo F; Kanomata N; Hattori K
IJU Case Rep; 2022 Sep; 5(5):415-417. PubMed ID: 36090924
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
11. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Castration-Resistant Prostate Cancer after Prostatectomy Treated with Resection of A Solitary Metastatic Site].
Araki H; Igarashi A; Uchida T; Manabe Y; Miyazaki Y; Ito H; Mishina M; Okuno H
Hinyokika Kiyo; 2020 Dec; 66(12):453-457. PubMed ID: 33435657
[TBL] [Abstract][Full Text] [Related]
13. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
14. Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/ml or greater.
Makino K; Nakagawa T; Ito E; Kasahara I; Murata T; Fujimura T; Fukuhara H; Homma Y
Jpn J Clin Oncol; 2018 May; 48(5):485-490. PubMed ID: 29635526
[TBL] [Abstract][Full Text] [Related]
15. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
Kosaka T; Hongo H; Oya M
BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
[TBL] [Abstract][Full Text] [Related]
16. Geriatric 8 screening of frailty in patients with prostate cancer.
Momota M; Hatakeyama S; Soma O; Tanaka T; Hamano I; Fujita N; Okamoto T; Yoneyama T; Yamamoto H; Imai A; Yoshikawa K; Yoneyama T; Hashimoto Y; Ohyama C
Int J Urol; 2020 Aug; 27(8):642-648. PubMed ID: 32500621
[TBL] [Abstract][Full Text] [Related]
17. Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer.
Takagi K; Kawase M; Kato D; Kawase K; Takai M; Iinuma K; Nakane K; Hagiwara N; Yamada T; Tomioka M; Koie T
Curr Oncol; 2022 Apr; 29(4):2864-2870. PubMed ID: 35448207
[TBL] [Abstract][Full Text] [Related]
18. Oncological Outcome of Combining Cytoreductive Prostatectomy and Metastasis-Directed Radiotherapy in Patients with Prostate Cancer and Bone Oligometastases: A Retrospective Cohort Study.
Xue P; Wu Z; Wang K; Gao G; Zhuang M; Yan M
Cancer Manag Res; 2020; 12():8867-8873. PubMed ID: 33061582
[TBL] [Abstract][Full Text] [Related]
19. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor.
Vives Dilme R; Rivas JG; Fernández Hernández L; De la Parra Sánchez I; Sánchez Del Hoyo R; Galante Romo MI; Redondo González E; Senovilla Pérez JL; Fernández Montarroso L; Moreno Sierra J
Ther Adv Urol; 2024; 16():17562872241229250. PubMed ID: 38333072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
